Literature DB >> 11401834

p21-activated kinase 1 participates in tracheal smooth muscle cell migration by signaling to p38 Mapk.

M A Dechert1, J M Holder, W T Gerthoffer.   

Abstract

Cell migration contributes to many physiological processes and requires dynamic changes in the cytoskeleton. These migration-dependent cytoskeletal changes are partly mediated by p21-activated protein kinases (PAKs). At least four closely related isoforms, PAK1, PAK2, PAK3, and PAK4, exist in mammalian cells. In smooth muscle cells, little is known about the expression, activation, or ability of PAKs to regulate migration. Our study revealed the existence of three PAK isoforms in cultured tracheal smooth muscle cells (TSMCs). Additionally, we constructed adenoviral vectors encoding wild type and a catalytically inactive PAK1 mutant to investigate PAK activation and its role in TSMC migration. Stimulation of TSMCs with platelet-derived growth factor (PDGF) increased the activity of PAK1 over time. Overexpression of mutant PAK1 blocked PDGF-induced chemotactic cell migration. Phosphorylation of p38 mitogen-activated protein kinase (MAPK) in cells overexpressing wild-type PAK1 was similar to vector controls; however, p38 MAPK phosphorylation was severely reduced by overexpression of the PAK1 mutant. Collectively, these results suggest a role for PAK1 in chemotactic TSMC migration that involves catalytic activity and may require signaling to p38 MAPK among other pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401834     DOI: 10.1152/ajpcell.2001.281.1.C123

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  31 in total

Review 1.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

Review 2.  Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration.

Authors:  J Kelley Bentley; Marc B Hershenson
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 3.  Migration of airway smooth muscle cells.

Authors:  William T Gerthoffer
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 4.  Intermediate filaments in smooth muscle.

Authors:  Dale D Tang
Journal:  Am J Physiol Cell Physiol       Date:  2008-02-06       Impact factor: 4.249

5.  The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.

Authors:  Bernardo Nuche-Berenguer; Irene Ramos-Álvarez; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2016-02-18

Review 6.  Small heat shock proteins in smooth muscle.

Authors:  Sonemany Salinthone; Manoj Tyagi; William T Gerthoffer
Journal:  Pharmacol Ther       Date:  2008-05-16       Impact factor: 12.310

7.  Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice.

Authors:  Laura J Sommerville; Sheri E Kelemen; Michael V Autieri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-08       Impact factor: 8.311

8.  Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB.

Authors:  Wei Li; Jianhua Fan; Mei Chen; Shengxi Guan; David Sawcer; Gary M Bokoch; David T Woodley
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

9.  Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Authors:  Thuy-Vi V Nguyen; Veronica Galvan; Wei Huang; Surita Banwait; Huidong Tang; Junli Zhang; Dale E Bredesen
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

10.  p21-activated kinase 1 participates in vascular remodeling in vitro and in vivo.

Authors:  Akinari Hinoki; Keita Kimura; Sadaharu Higuchi; Kunie Eguchi; Akira Takaguri; Kazuhiro Ishimaru; Gerald D Frank; William T Gerthoffer; Laura J Sommerville; Michael V Autieri; Satoru Eguchi
Journal:  Hypertension       Date:  2009-11-09       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.